Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, selectively induces growth suppression and cell death of endometrial stromal sarcoma cells in vitro

被引：0
|
作者：
Hrzenjak, Andelko [1 ]
Moinfar, Farid [1 ]
Kremser, Marie-Luise [1 ]
Strohmeier, Bettina [1 ]
Zatloukal, Kurt [1 ]
Denk, Helmut [1 ]
机构：
[1] Med Univ Graz, Dept Pathol, Graz, Austria
来源：
VIRCHOWS ARCHIV | 2007年 / 451卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：401 / 401
页数：1
相关论文
共 50 条
  • [1] The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Induces Differentiation of Intestinal Cells
    Roostaee, Alireza
    Benoit, Yannick D.
    Guezguez, Amel
    Simoneau, Aline
    Beaulieu, Jean-Francois
    GASTROENTEROLOGY, 2014, 146 (05) : S785 - S785
  • [2] Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
    Butler, LM
    Agus, DB
    Scher, HI
    Higgins, B
    Rose, A
    Cordon-Cardo, C
    Thaler, HT
    Rifkind, RA
    Marks, PA
    Richon, VM
    CANCER RESEARCH, 2000, 60 (18) : 5165 - 5170
  • [3] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells
    Munster, PN
    Troso-Sandoval, T
    Rosen, N
    Rifkind, R
    Marks, PA
    Richon, VM
    CANCER RESEARCH, 2001, 61 (23) : 8492 - 8497
  • [4] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancer
    Arnold, Nichole Boyer
    Arkus, Nolhea
    Gunn, Jason
    Korc, Murray
    CLINICAL CANCER RESEARCH, 2007, 13 (01) : 18 - 26
  • [5] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer
    Shi, Yi-kang
    Li, Zhong-hua
    Han, Xi-qian
    Yi, Ji-hu
    Wang, Zhen-hua
    Hou, Jing-li
    Feng, Cong-ran
    Fang, Qing-hong
    Wang, Hui-hui
    Zhang, Peng-fei
    Wang, Feng-shan
    Shen, Jie
    Wang, Peng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (06) : 1131 - 1140
  • [6] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer
    Yi-kang Shi
    Zhong-hua Li
    Xi-qian Han
    Ji-hu Yi
    Zhen-hua Wang
    Jing-li Hou
    Cong-ran Feng
    Qing-hong Fang
    Hui-hui Wang
    Peng-fei Zhang
    Feng-shan Wang
    Jie Shen
    Peng Wang
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 1131 - 1140
  • [7] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor:: Effects on gene expression and growth of glioma cells in vitro and in vivo
    Yin, Dong
    Ong, John M.
    Hu, Jinwei
    Desmond, Julian C.
    Kawamata, Norihiko
    Konda, Bindu M.
    Black, Keith L.
    Koeffler, H. Phillip
    CLINICAL CANCER RESEARCH, 2007, 13 (03) : 1045 - 1052
  • [8] The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) radiosensitizes osteosarcoma cells in vitro and in vivo
    Schlaich, F.
    Blattmann, C.
    Thiemann, M.
    Kulozik, A. E.
    Debus, J.
    Oertel, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 119 - 120
  • [9] The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces growth arrest and apoptosis in human retinoblastoma cell lines
    Poulaki, V
    Joussen, A
    Iliaki, E
    Mitsiades, CS
    Fanourakis, G
    Mitsiades, N
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U255 - U255
  • [10] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, in relapsed leukemias
    不详
    CLINICAL LYMPHOMA, 2004, 5 (02): : 78 - 79
12345